AI assistant
Sending…
Liquidia Corp — Director's Dealing 2022
Sep 8, 2022
31694_dirs_2022-09-07_53660cc8-8cfd-46f2-87f6-f4a1017fc681.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2022-09-06
Reporting Person: JEFFS ROGER (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-06 | Common Stock | P | 43820 | $5.568 | Acquired | 159827 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 46595 | Indirect |
| Common Stock | 1541667 | Indirect |
Footnotes
F1: Price is the volume weighted average purchase price of all purchases made by the Reporting Person on the transaction date for prices ranging from $5.47 to $5.68.
F2: The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F3: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.
More from Liquidia Corp
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 3